FDA Announces OMB Approval for Lyme Vaccine Study Questionnaire

Summary

The FDA has announced that it has received approval from the Office of Management and Budget (OMB) to administer a telephone questionnaire to participants in an FDA Lyme vaccine safety study, as part of a larger case-control study examining the effects of the vaccine on HLA type and T-cell reactivity.